J. Yeaman Kevin's most recent trade in Dolby Laboratories Inc - Ordinary Shares - Class A was a trade of 145,252 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Feb 2026 | 145,252 | 145,252 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Feb 2026 | 145,252 | 145,252 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2025 | 145,252 | 145,252 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2025 | 65,968 | 193,703 (0%) | 0% | 0 | Class A Common Stock | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2025 | 32,984 | 32,984 | - | - | Performance-Based Restricted Stock Unit | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.54 per share. | 15 Dec 2025 | 27,180 | 157,390 (0%) | 0% | 67.5 | 1,835,737 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 66.64 per share. | 15 Dec 2025 | 21,772 | 110,122 (0%) | 0% | 66.6 | 1,450,895 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 17,633 | 0 | - | - | Performance-Based Restricted Stock Unit | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 17,633 | 202,587 (0%) | 0% | 0 | Class A Common Stock | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.62 per share. | 15 Dec 2025 | 6,855 | 143,784 (0%) | 0% | 66.6 | 456,680 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 67.24 per share. | 15 Dec 2025 | 6,671 | 98,457 (0%) | 0% | 67.2 | 448,525 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 67.16 per share. | 15 Dec 2025 | 4,994 | 105,128 (0%) | 0% | 67.2 | 335,415 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 67.54 per share. | 15 Dec 2025 | 80 | 98,377 (0%) | 0% | 67.5 | 5,403 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 66.99 per share. | 09 Dec 2025 | 28,168 | 104,576 (0%) | 0% | 67.0 | 1,887,028 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2025 | 23,752 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 09 Dec 2025 | 23,752 | 132,744 (0%) | 0% | 45.5 | 1,080,716 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.60 per share. | 09 Dec 2025 | 10,615 | 108,992 (0%) | 0% | 64.6 | 685,729 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2025 | 10,615 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 67.51 per share. | 09 Dec 2025 | 6,199 | 98,377 (0%) | 0% | 67.5 | 418,465 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 66.91 per share. | 24 Nov 2025 | 36,699 | 114,725 (0%) | 0% | 66.9 | 2,455,405 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 25,000 | 10,615 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 24 Nov 2025 | 25,000 | 139,725 (0%) | 0% | 45.5 | 1,137,500 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Nov 2025 | 16,348 | 98,377 (0%) | 0% | 0 | Class A Common Stock | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 11,699 | 23,752 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.60 per share. | 24 Nov 2025 | 11,699 | 151,424 (0%) | 0% | 64.6 | 755,755 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2025 | 25,000 | 35,615 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 14 Oct 2025 | 25,000 | 139,725 (0%) | 0% | 45.5 | 1,137,500 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 69.17 per share. | 14 Oct 2025 | 13,786 | 114,725 (0%) | 0% | 69.2 | 953,619 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 68.51 per share. | 14 Oct 2025 | 11,214 | 128,511 (0%) | 0% | 68.5 | 768,223 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2025 | 25,000 | 60,615 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 71.66 per share. | 16 Sep 2025 | 25,000 | 114,725 (0%) | 0% | 71.7 | 1,791,490 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 16 Sep 2025 | 25,000 | 139,725 (0%) | 0% | 45.5 | 1,137,500 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 25,000 | 85,615 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 72.31 per share. | 12 Aug 2025 | 25,000 | 114,725 (0%) | 0% | 72.3 | 1,807,828 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 12 Aug 2025 | 25,000 | 139,725 (0%) | 0% | 45.5 | 1,137,500 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 74.81 per share. | 15 Jul 2025 | 39,595 | 115,005 (0%) | 0% | 74.8 | 2,962,205 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 15 Jul 2025 | 25,000 | 139,725 (0%) | 0% | 45.5 | 1,137,500 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 25,000 | 110,615 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 14,875 | 37,942 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.60 per share. | 15 Jul 2025 | 14,875 | 154,600 (0%) | 0% | 64.6 | 960,925 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 2,491 | 35,451 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 15 Jul 2025 | 2,491 | 114,725 (0%) | 0% | 75 | 186,825 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.60 per share. | 15 Jul 2025 | 2,491 | 117,216 (0%) | 0% | 64.6 | 160,919 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 75.30 per share. | 15 Jul 2025 | 280 | 114,725 (0%) | 0% | 75.3 | 21,085 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2025 | 25,000 | 135,615 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 24 Jun 2025 | 25,000 | 139,725 (0%) | 0% | 45.5 | 1,137,500 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 74.02 per share. | 24 Jun 2025 | 25,000 | 114,725 (0%) | 0% | 74.0 | 1,850,530 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 76.22 per share. | 10 Jun 2025 | 33,504 | 114,904 (0%) | 0% | 76.2 | 2,553,775 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 25,000 | 160,615 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 10 Jun 2025 | 25,000 | 139,725 (0%) | 0% | 45.5 | 1,137,500 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 8,683 | 52,817 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.60 per share. | 10 Jun 2025 | 8,683 | 148,408 (0%) | 0% | 64.6 | 560,922 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 76.57 per share. | 10 Jun 2025 | 179 | 114,725 (0%) | 0% | 76.6 | 13,706 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Feb 2025 | 95,671 | 95,671 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Feb 2025 | 95,671 | 95,671 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | J. Kevin Yeaman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 95,671 | 95,671 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | J. Kevin Yeaman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 54,425 | 174,745 (0%) | 0% | 0 | Class A Common Stock | |
| Dolby Laboratories Inc (Class A) | Kevin Yeaman J. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.18 per share. | 16 Dec 2024 | 31,483 | 127,735 (0%) | 0% | 79.2 | 2,492,824 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | J. Yeaman Kevin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 27,212 | 27,212 | - | - | Performance-Based Restricted Stock Unit | |
| Dolby Laboratories Inc (Class A) | J. Kevin Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 15,477 | 182,543 (0%) | 0% | 0 | Class A Common Stock | |
| Dolby Laboratories Inc (Class A) | Yeaman Kevin J. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 15,477 | 0 | - | - | Performance-Based Restricted Stock Unit | |
| Dolby Laboratories Inc (Class A) | Yeaman Kevin J. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.32 per share. | 25 Oct 2024 | 50,000 | 133,721 (0%) | 0% | 62.3 | 3,116,000 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2024 | 50,000 | 7,888 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | J. Kevin Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 80.53 per share. | 25 Oct 2024 | 49,104 | 84,617 (0%) | 0% | 80.5 | 3,954,232 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.32 per share. | 25 Oct 2024 | 7,888 | 91,609 (0%) | 0% | 62.3 | 491,580 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2024 | 7,888 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Yeaman J. Kevin | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 80.19 per share. | 25 Oct 2024 | 7,888 | 83,721 (0%) | 0% | 80.2 | 632,539 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin Yeaman J. | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 81.18 per share. | 25 Oct 2024 | 896 | 83,721 (0%) | 0% | 81.2 | 72,734 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 100.00 per share. | 17 Jun 2024 | 2 | 2 (0%) | 0% | 100 | 200 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2024 | 81,884 | 81,884 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Yeaman J. Kevin | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2024 | 81,884 | 81,884 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Yeaman J. Kevin | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 83.51 per share. | 17 Jan 2024 | 9,030 | 83,721 (0%) | 0% | 83.5 | 754,083 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | J. Yeaman Kevin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2024 | 8,784 | 185,615 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 17 Jan 2024 | 8,784 | 92,751 (0%) | 0% | 45.5 | 399,672 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | J. Yeaman Kevin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 17 Jan 2024 | 246 | 83,967 (0%) | 0% | 43.0 | 10,573 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | J. Yeaman Kevin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2024 | 246 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Yeaman J. Kevin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 81,884 | 81,884 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | J. Kevin Yeaman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 46,718 | 166,275 (0%) | 0% | 0 | Class A Common Stock | |
| Dolby Laboratories Inc (Class A) | J. Yeaman Kevin | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.60 per share. | 15 Dec 2023 | 26,047 | 130,945 (0%) | 0% | 88.6 | 2,307,764 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | J. Yeaman Kevin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 23,359 | 23,359 | - | - | Performance-Based Restricted Stock Unit | |
| Dolby Laboratories Inc (Class A) | J. Yeaman Kevin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 17,202 | 174,804 (0%) | 0% | - | Class A Common Stock | |
| Dolby Laboratories Inc (Class A) | J. Kevin Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 17,202 | 0 | - | - | Performance-Based Restricted Stock Unit | |
| Dolby Laboratories Inc (Class A) | Yeaman Kevin J. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.49 per share. | 15 Dec 2023 | 5,268 | 120,320 (0%) | 0% | 87.5 | 460,897 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Yeaman J. Kevin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 18,060 | 246 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | J. Kevin Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 12 Dec 2023 | 18,060 | 69,939 (0%) | 0% | 43.0 | 776,219 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Yeaman J. Kevin | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 89.17 per share. | 12 Dec 2023 | 18,060 | 51,879 (0%) | 0% | 89.2 | 1,610,435 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2023 | 45,150 | 18,306 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 21 Nov 2023 | 45,150 | 97,029 (0%) | 0% | 43.0 | 1,940,547 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 21 Nov 2023 | 36,120 | 51,879 (0%) | 0% | 85 | 3,070,200 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 83.98 per share. | 21 Nov 2023 | 9,030 | 87,999 (0%) | 0% | 84.0 | 758,378 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 17 Oct 2023 | 9,030 | 60,909 (0%) | 0% | 43.0 | 388,109 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Oct 2023 | 9,030 | 63,456 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 82.49 per share. | 17 Oct 2023 | 7,054 | 52,179 (0%) | 0% | 82.5 | 581,851 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 81.53 per share. | 17 Oct 2023 | 1,676 | 59,233 (0%) | 0% | 81.5 | 136,642 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 82.89 per share. | 17 Oct 2023 | 300 | 51,879 (0%) | 0% | 82.9 | 24,866 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2023 | 18,060 | 72,486 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 12 Sep 2023 | 18,060 | 69,939 (0%) | 0% | 43.0 | 776,219 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 82.56 per share. | 12 Sep 2023 | 16,711 | 53,228 (0%) | 0% | 82.6 | 1,379,735 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 83.31 per share. | 12 Sep 2023 | 1,349 | 51,879 (0%) | 0% | 83.3 | 112,385 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 11 Jul 2023 | 27,090 | 51,879 (0%) | 0% | 90 | 2,438,100 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 11 Jul 2023 | 27,090 | 78,969 (0%) | 0% | 43.0 | 1,164,328 | Class A Common Stock |